Sponsor

Institut Cancerologie de l'Ouest

Clinical research sponsor

Published trials59
Recruiting shown6
Roles2
SourceClinicalTrials.gov

Clinical trials

59 shown
HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS)NCT06978296 · lead sponsor · 2026-06-01
RECRUITING
Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer PatientsNCT06962163 · lead sponsor · 2025-12-05
RECRUITING
To Assess the Contribution of Sophrology Assisted by an Ambulatory Device on the Anxiety of Patients Undergoing Chemotherapy for the Treatment of Localized Breast CancerNCT06800989 · lead sponsor · 2025-05-15
RECRUITING
Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer PatientsNCT05981326 · lead sponsor · 2023-10-31
RECRUITING
Clinico-biological Data Collection Study of Metastatic Lung CancerNCT04944030 · lead sponsor · 2023-04-24
RECRUITING
Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in SituNCT04666961 · lead sponsor · 2021-02-03
RECRUITING
Evaluation of the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC)NCT07007325 · lead sponsor · 2026-09-30
NOT_YET_RECRUITING
Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatase Inhibitor-induced Arthralgia (AIA)NCT07575750 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder CancerNCT07468838 · lead sponsor · 2026-05-01
NOT_YET_RECRUITING
Clinical and Biological Study of Early-onset Breast Cancer and the Influence of the Reproductive Cycle on the Aggressiveness of the DiseaseNCT07601152 · lead sponsor · 2026-05-01
NOT_YET_RECRUITING
Reproductive Health in Breast Cancer SurvivorNCT06756802 · lead sponsor · 2025-12-01
ACTIVE_NOT_RECRUITING
Music Therapy as a Tool for Anxiety Reduction in Localized Breast CancerNCT05856656 · lead sponsor · 2023-10-10
COMPLETED
Pain and Functional Recovery After Mastectomy and IBR by Implant: Prepectoral Versus Subpectoral TechniqueNCT05527769 · lead sponsor · 2022-09-07
COMPLETED
Retrospective and Prospective Evaluation of Scapulohumeral Comfort, Aesthetic Result and Quality of LifeNCT05316389 · lead sponsor · 2022-02-21
COMPLETED
Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to ImmunotherapyNCT05111197 · lead sponsor · 2022-01-12
UNKNOWN
Electrotherapy in the Management of Myofascial SyndromeNCT04936451 · lead sponsor · 2022-01-05
TERMINATED
Detection and Metabolic Characterization in DOPA PET/CT of Brain MetastasesNCT04890028 · lead sponsor · 2021-12-03
COMPLETED
Evaluating Smoking Cessation Protocols in Cancer Patients: NRT, MI, CBT or HypnotherapyNCT04899492 · lead sponsor · 2021-09-29
TERMINATED
Imaging Performance Assessment of 89Zi-girentuximab (89Zr-TLX250) PET in Metastatic Triple Negative Breast CancerNCT04758780 · lead sponsor · 2021-09-21
COMPLETED
Breast Reconstruction by Exclusive Lipomodulin : Feasibility, Evaluation of the Aesthetic Result and Quality of LifeNCT04625621 · lead sponsor · 2020-11-26
COMPLETED
Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by MetforminNCT04536805 · lead sponsor · 2020-11-17
ACTIVE_NOT_RECRUITING
Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate TumorsNCT04704804 · lead sponsor · 2020-07-24
COMPLETED
Patients and Health Staff of Cancer Centres During the Covid-19 PandemicNCT04421625 · lead sponsor · 2020-06-15
COMPLETED
[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast CancersNCT04320030 · lead sponsor · 2020-06-11
COMPLETED
Delayed Breast Reconstruction by Prepectoral Implant After Lipo-preparation (RM2prepec)NCT04343820 · lead sponsor · 2019-12-24
COMPLETED
Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in OncologyNCT03948724 · lead sponsor · 2019-12-11
COMPLETED
Bringing of PET-TDM FDG in the Determination of the Characteristics of Primary Mammary Tumors TrIple NegativesNCT04226222 · lead sponsor · 2019-11-05
UNKNOWN
Interest of Touch-massage in Hospital Day CareNCT04348955 · lead sponsor · 2019-10-07
COMPLETED
Satisfaction and QUality of Life After Breast REconstructionNCT04329819 · lead sponsor · 2019-09-03
COMPLETED
Intravenous Chemotherapy and Plant-based Dietary SupplementsNCT03959618 · lead sponsor · 2019-04-02
COMPLETED
Study of the Response to Irradiation on Prostatic Explants ex Vivo, as a Predictive Factor of the Clinical Response to Irradiation of Prostate CancersNCT03961737 · lead sponsor · 2019-04-02
UNKNOWN
Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)NCT03795207 · lead sponsor · 2019-03-21
ACTIVE_NOT_RECRUITING
Evaluation in the Treatment of Neuropathic Pain Post Breast SurgeryNCT03794388 · lead sponsor · 2019-03-19
COMPLETED
Sentinel Lymph Node After Neoadjuvant Chemotherapy in Breast CarcinomaNCT03630913 · lead sponsor · 2019-01-08
UNKNOWN
Clinico-biological Data Collection Study of Metastatic Breast CancerNCT03958136 · lead sponsor · 2018-12-24
ACTIVE_NOT_RECRUITING
Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer PatientsNCT03630666 · lead sponsor · 2018-12-04
ACTIVE_NOT_RECRUITING
Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer RelapseNCT03630653 · lead sponsor · 2018-05-29
TERMINATED
Study of 68Ga-HBED-PSMA PET/CT and Conventional Imaging in Occult Biological Relapse Prostate CancerNCT03443609 · lead sponsor · 2017-03-31
COMPLETED
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast CancerNCT03442504 · lead sponsor · 2017-03-15
UNKNOWN
Quality of Life and Psychological Vulnerability in Patients With RH+ Metastatic Breast CancerNCT03636776 · lead sponsor · 2016-12-29
TERMINATED
Evaluation of Impact of Sandostatin® Injection Before Axillary Clearance on Lymphocele FormationNCT03791736 · lead sponsor · 2016-07-06
TERMINATED
Women at Risk of Breast Cancer and OLFM4NCT02653105 · lead sponsor · 2016-03-08
ACTIVE_NOT_RECRUITING
Persistent Organic Pollutants and Breast Cancers (POPCASE)NCT02890095 · lead sponsor · 2016-01-01
ACTIVE_NOT_RECRUITING
Comparing Palliative Radiotherapy With or Without CarboplatinNCT03637335 · lead sponsor · 2015-08-17
TERMINATED
Longitudinal Study of Behavioral Changes, Economic and Sociological After CAncerNCT02893774 · lead sponsor · 2015-03-12
COMPLETED
Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate CancerNCT02876237 · lead sponsor · 2015-02-01
COMPLETED
Retroprospective Real Life Observatory of EribulinNCT02393287 · lead sponsor · 2014-11-01
COMPLETED
Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate CancerNCT02274779 · lead sponsor · 2014-08-20
COMPLETED
Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast CancerNCT02890082 · lead sponsor · 2014-02-01
ACTIVE_NOT_RECRUITING
Medico-economic Study of Three Strategies of Sentinel Lymph Node Analysis in Operable Breast CancerNCT02056886 · lead sponsor · 2013-10-21
COMPLETED
Evaluation of Hypoxia by PET With F-Miso in Radiation Therapy of Prostate CancerNCT01898065 · lead sponsor · 2012-06-01
COMPLETED
Medico Economic Study, Comparing Intrabeam® on Surgical Resection Bed to Conventional Surgery + EBRT, in Breast CancerNCT03637738 · lead sponsor · 2012-06-01
UNKNOWN
Medico-economic Evaluation of IMRT by Hi Art, RapidArc, VMAT Therapy in Prostate, Cervix and Anal Canal CancersNCT01325961 · lead sponsor · 2011-03-01
COMPLETED
ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate AdenocarcinomaNCT01219790 · lead sponsor · 2010-10-01
COMPLETED
Sentinel Lymph Node Detection After Neoadjuvant Chemotherapy for Large Operable Breast CancerNCT01221688 · lead sponsor · 2010-07-12
COMPLETED
Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+NCT01220076 · lead sponsor · 2009-09-01
COMPLETED
RSHF in Colorectal CancerNCT01220063 · lead sponsor · 2007-10-19
COMPLETED
Study of Sentinel Lymph Node Assessment Following Previous Surgical Biopsy for Early Breast CancerNCT00293865 · lead sponsor · 2006-03-01
COMPLETED
A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast CancerNCT01548534 · collaborator · 2012-02-01
TERMINATED

Sponsor roles

lead sponsor58
collaborator1

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.